Comparison of CSvO2 percentages in fetuses and neonates in the literature
| Study | CSvO2 (mean) (%) | Method | Subjects | Region |
|---|---|---|---|---|
| van der Hoeven et al57 | 73.56 (SD, 5.25) | Fiber optic catheter | Healthy neonates | |
| Buchvald et al58 | 64.12 (SD, 4.6) | NIRS | Healthy neonates | Frontotemporal region |
| Wintermark et al59 | 77.3 (SD, 4.7) | NIRS | Hypothermia therapy (moderate) in neonatal HIE | Frontal lobe |
| Wintermark et al59 | 77.6 (SD, 6.6) | NIRS | Hypothermia therapy (severe) in neonatal HIE | Frontal lobe |
| De Vis et al60 | 65.0 (SD, 13.0 | T2-TRIR | Healthy neonates | SSS |
| Shetty et al48 | 73.2 (SD, 5.5) | TRUST | Hypothermia therapy in neonatal HIE | SSS |
| Shetty et al48 | 68.5 (SD, 9.6) | TRUST | Post-hypothermia therapy in neonatal HIE | SSS |
| Liu et al49 | 62.6 (SD, 8.3) | TRUST | Healthy neonates | SSS |
| Yadav et al44 | 67 (SD, 7) | QSM | Healthy fetuses (∼31 wk) | SSS |
| Jain et al45 | 55.2 | Susceptometry | Neonates with congenital heart disease | SSS |
| Yadav et al46 | 62.6 (SD, 3.25) | Susceptometry | Healthy fetuses (∼31 wk) | SSS |
| Neelavalli et al47 | 66 (SD, 9.4) | Susceptometry | Healthy fetuses (∼34 wk) | SSS |
| Average | 68.12 |
Note:—T2-TRIR indicates T2-prepared tissue relaxation inversion recovery; SSS, superior sagittal sinus; TRUST, T2-relaxation-under-spin tagging; QSM, quantitative susceptibility mapping; NIRS, near infrared resonance spectroscopy.